₹ 2,216.20
-63.80 (-2.80%)
E
Emcure Pharmaceuticals
₹ 2,216.20
Emcure Pharmaceuticals Share Price Today
Emcure Pharmaceuticals (EMCURE) share price is trading at ₹2,216.20 on the NSE as of November 9, 2026 at 03:50 PM, down by 2.80% from its previous close of ₹2,280.00. In todays trading session EMCURE reached a high of 2,280.00 and low of 2,196.60. The average traded price for today is 2,236.14. The 50 DMA stands at 1,928.79 and 200 DMA is at 1,744.33. Looking at intraday trend, the stock is in Downtrend.
Stock Overview
- Symbol : EMCURE
- Open : ₹2,280.00
- Previous Close : ₹2,280.00
- Day's Range : ₹2,196.60 – ₹2,280.00
- 52-Week Range : ₹1,312.30 – ₹2,429.90
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
EMCURE Stock Performance
Markets Today
High
2,280.00
Low
2,196.60
Open at
2,280.00
Prev Close
2,280.00
Volumes
2,60,165
Avg Price
2,236.14
Lower Circuit
1,994.60
Upper Circuit
2,437.80
Last Traded Details
Quantity
20
Time
15:50:19
Price Movement
Historical Performance
3 M High
2,429.90
3 M Low
1,716.00
1 Yr High
2,429.90
1 Yr Low
1,312.30
3 Yr High
2,429.90
3 Yr Low
889.00
5 Yr High
2,429.90
5 Yr Low
889.00
1-Year Performance
EMCURE Pros and Cons
Revenue grew from ₹2,470 Cr in Q4 FY26 to ₹28,205 Cr in Q2 FY27, driven by international expansion
EBITDA margin improved from 19.7% in Q4 FY26 to 20.4% in Q2 FY27, showing better operational efficiency
EU revenue share rose from 20% in Q4 FY26 to 36% in Q2 FY27, highlighting strong European demand
Return on Capital Employed increased from 23.7% in Q4 FY26 to 24.9% in Q2 FY27, indicating better capital efficiency
Net debt spiked from ₹1,054 Cr in Q4 FY26 to ₹13,171 Cr in Q2 FY27, signaling a significant increase in leverage
Capital Expenditure jumped from ₹434 Cr in Q4 FY26 to ₹1,648 Cr in Q2 FY27, indicating aggressive capacity expansion
Domestic revenue share dropped from 44% in Q4 FY26 to 12% in Q2 FY27, reflecting a pivot to international markets
EMCURE Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 9 analysts
Buy
88.89%
Hold
11.11%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
EMCURE Share Price History
EMCURE Fundamentals
Company Valuation
Market Cap (₹ Cr.)
42,044
PE Ratio
39.60
PB Ratio
8.10
Dividend Yield
0.16%
ROE
18.91%
ROCE
25.10%
Book Value (₹)
281.69
Face Value (₹)
10.00
Analyse EMCURE with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 77.88% | 77.87% | 77.87% | 77.83% | 77.82% |
| Domestic Institutional Investors (DII) | 4.37% | 6.10% | 6.10% | 8.46% | 8.49% |
| Foreign Institutional Investors (FII) | 3.29% | 3.59% | 3.35% | 4.88% | 4.94% |
| Public Investors | 6.24% | 6.46% | 6.46% | 6.45% | 6.34% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Emcure Pharmaceuticals Return Calculator
Note: Past profits do not guarantee future returns.
EMCURE Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
EMCURE Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for EMCURE
Margin on EMCURE
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
EMCURE Financials Summary
In Crores
EMCURE Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check EMCURE latest Company Filings, Investor Presentation & Conference Call details.
EMCURE Revenue Growth
All values are in Crores
Revenue
Profit
Loss
EMCURE Similar Stocks
FAQs on EMCURE
What is the share price of Emcure Pharmaceuticals?
What is the 52W high and 52W low of Emcure Pharmaceuticals?
What is the return on Emcure Pharmaceuticals share?
- Past 1 year: 62.67%
- Past 3 years: 63.06%
- Past 5 years: 63.06%
What is the PE and PB Ratio of Emcure Pharmaceuticals?
What is the EPS of Emcure Pharmaceuticals?
What is the shareholding pattern of Emcure Pharmaceuticals?
- DIIs - 8.49%
- FII - 4.94%
- Promoters - 77.82%
- Public Investors 6.34%
- Goverenment - 0.00%
How to buy Emcure Pharmaceuticals shares online?
How to buy Emcure Pharmaceuticals shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Emcure Pharmaceuticals share
- Tap on “Buy”
